Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 201.00
+6.20 (3.18%)
Nov 4, 2026, 5:29 PM CET
Xvivo Perfusion AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,331 | 5,878 | 15,403 | 10,379 | 5,459 | 8,215 | |
Market Cap Growth | 6.07% | -61.84% | 48.41% | 90.12% | -33.55% | -8.90% |
Enterprise Value | 6,139 | 5,722 | 14,978 | 9,810 | 5,150 | 7,936 |
Last Close Price | 201.00 | 186.60 | 489.00 | 329.50 | 183.00 | 278.50 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 49.14 | 233.59 | 89.46 | 113.04 | 296.26 | 1007.78 |
Forward PE | 40.91 | 51.19 | 92.61 | 199.34 | 111.93 | 211.39 |
PS Ratio | 6.60 | 7.24 | 18.73 | 17.37 | 13.15 | 31.80 |
PB Ratio | 2.79 | 2.78 | 7.14 | 5.34 | 3.82 | 6.39 |
P/TBV Ratio | 4.01 | 4.01 | 10.81 | 7.84 | 6.86 | 10.06 |
P/FCF Ratio | 36.17 | 800.25 | 379.77 | 3172.09 | 564.50 | - |
P/OCF Ratio | 23.56 | 58.16 | 138.41 | 224.23 | 195.98 | - |
PEG Ratio | - | 3.51 | 3.51 | 3.51 | 3.51 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.40 | 7.05 | 18.21 | 16.42 | 12.40 | 30.71 |
EV/EBITDA Ratio | 32.15 | 44.25 | 126.47 | 515.41 | 387.15 | - |
EV/EBIT Ratio | 48.05 | 60.61 | 164.89 | 1818.08 | 1156.32 | - |
EV/FCF Ratio | 35.07 | 779.09 | 369.29 | 2998.27 | 532.54 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.05 | 0.06 | 0.02 | 0.02 | 0.01 | 0.00 |
Debt / EBITDA Ratio | 0.63 | 0.88 | 0.26 | 1.06 | 0.51 | - |
Debt / FCF Ratio | 0.69 | 16.98 | 0.84 | 9.61 | 1.03 | - |
Net Debt / Equity Ratio | -0.08 | -0.08 | -0.18 | -0.26 | -0.16 | -0.31 |
Net Debt / EBITDA Ratio | -1.08 | -1.29 | -3.22 | -27.04 | -17.78 | 33.59 |
Net Debt / FCF Ratio | -1.10 | -22.79 | -9.41 | -157.29 | -24.46 | 17.66 |
Asset Turnover | 0.39 | 0.34 | 0.36 | 0.30 | 0.25 | 0.19 |
Inventory Turnover | 1.08 | 0.89 | 1.12 | 1.23 | 1.29 | 1.02 |
Quick Ratio | 2.69 | 3.44 | 3.14 | 4.94 | 2.60 | 4.43 |
Current Ratio | 3.92 | 5.77 | 4.58 | 6.15 | 3.47 | 5.24 |
Return on Equity (ROE) | 5.91% | 1.18% | 8.39% | 5.44% | 1.36% | 0.71% |
Return on Assets (ROA) | 3.22% | 2.47% | 2.47% | 0.17% | 0.17% | -0.87% |
Return on Invested Capital (ROIC) | 5.17% | 3.31% | 4.88% | 0.40% | 0.35% | -2.41% |
Return on Capital Employed (ROCE) | 5.30% | 4.20% | 4.10% | 0.30% | 0.30% | -1.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.03% | 0.43% | 1.12% | 0.89% | 0.34% | 0.10% |
FCF Yield | 2.76% | 0.13% | 0.26% | 0.03% | 0.18% | -0.27% |
Buyback Yield / Dilution | 0.06% | 0.29% | -5.73% | -1.39% | -2.04% | -6.49% |